|
AIMP1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.42489999999962E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.836820E-03 |
| Normal-vs-Stage2 |
3.822400E-01 |
| Normal-vs-Stage3 |
5.27800003702339E-09 |
| Normal-vs-Stage4 |
1.2576999997016E-07 |
| Stage1-vs-Stage2 |
3.688400E-01 |
| Stage1-vs-Stage3 |
1.021630E-04 |
| Stage1-vs-Stage4 |
4.263400E-03 |
| Stage2-vs-Stage3 |
8.564500E-03 |
| Stage2-vs-Stage4 |
2.097900E-02 |
| Stage3-vs-Stage4 |
5.699600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.69719999995899E-06 |
| Normal-vs-AfricanAmerican |
3.203800E-04 |
| Normal-vs-Asian |
1.923570E-01 |
| Caucasian-vs-AfricanAmerican |
7.937000E-01 |
| Caucasian-vs-Asian |
7.832000E-01 |
| AfricanAmerican-vs-Asian |
6.729600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.88907999999488E-05 |
| Normal-vs-Female |
1.643760E-03 |
| Male-vs-Female |
1.037650E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.018060E-03 |
| Normal-vs-Age(41-60Yrs) |
3.377600E-04 |
| Normal-vs-Age(61-80Yrs) |
4.92050000000521E-06 |
| Normal-vs-Age(81-100Yrs) |
3.639500E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.771800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.132400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.101800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.128600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.211170E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.765800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.175000E-01 |
| Normal-vs-Grade 2 |
1.811510E-02 |
| Normal-vs-Grade 3 |
2.91130000107387E-08 |
| Normal-vs-Grade 4 |
4.02680000455291E-10 |
| Grade 1-vs-Grade 2 |
1.898170E-01 |
| Grade 1-vs-Grade 3 |
1.018220E-02 |
| Grade 1-vs-Grade 4 |
4.028800E-04 |
| Grade 2-vs-Grade 3 |
5.375000E-04 |
| Grade 2-vs-Grade 4 |
7.72349999955679E-07 |
| Grade 3-vs-Grade 4 |
1.474350E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.330600E-01 |
| Normal-vs-ccB subtype |
7.75620012660738E-10 |
| ccA subtype-vs-ccB subtype |
1.41449996160503E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.405700E-04 |
| Normal-vs-N1 |
1.543990E-02 |
| N0-vs-N1 |
7.353600E-01 |
|
|
